© Civilization Ventures 2020 | All Rights Reserved.
IgA therapeutic monoclonal antibody platform to activate neutrophils for the treatment of solid tumors.
Menlo Park (CA)
Antheia is a synthetic biology company unlocking the medicinal power of nature. Through their pioneering approach to bioengineering and fermentation, they enable the discovery and production of plant-inspired drugs that would otherwise be impossible or highly inefficient to explore, make, and scale.
Evolve BioSystems is dedicated to developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome. Building on a decade of expertise in the partnership between the infant gut microbiome and human breast milk, Evolve is solving newborn gut dysbiosis, or an imbalance of beneficial bacteria, through microbiome-based interventions in both human and animal health.
Fluent BioScience’s proprietary reagent technology makes possible highly scalable molecular analysis, from individual rare gene fragments to millions of intact cells, all without complex user-side instrumentation or consumables. Fluent BioSciences is poised to transform a currently inefficient and complex market with a technology that offers speed and simplicity.
Los Angeles (CA)